Frazier Financial Advisors’s BioNTech BNTX Stock Holding History

Frazier Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.4K	Hold	262	–	–	0.01%	279
2026 Q1	$23.3K	Hold	262	–	–	0.01%	295
2025 Q4	$24.9K	Hold	262	–	–	0.01%	247
2025 Q3	$25.8K	Hold	262	–	–	0.02%	237
2025 Q2	$27.9K	Hold	262	–	–	0.02%	217
2025 Q1	$23.9K	Hold	262	–	–	0.02%	224
2024 Q4	$29.5K	Hold	262	–	–	0.02%	195
2024 Q3	$31.1K	Sell	262 -3	-1%	-$276	0.02%	201
2024 Q2	$21.3K	Sell	265 -18	-6%	-$1.65K	0.02%	278
2024 Q1	$26.1K	Sell	283 -3	-1%	-$288	0.02%	224
2023 Q4	$30.2K	Buy	+286	New	+$28.8K	0.03%	182

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Frazier Financial Advisors's BNTX Position: Q2 2026 in Review

Frazier Financial Advisors held its BioNTech (BNTX) position steady in Q2 2026 at 262 shares worth $24.4K. The position accounts for 0.01% of the portfolio, ranked #279.

Frazier Financial Advisors first reported a position in BNTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $31.1K in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Frazier Financial Advisors held 262 shares of BioNTech worth $24.4K as of Q2 2026.
Frazier Financial Advisors left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.01% of Frazier Financial Advisors's portfolio in Q2 2026, its #279 holding.
Frazier Financial Advisors first reported a position in BioNTech in Q4 2023 and has held it in 11 quarters since.
Frazier Financial Advisors's BioNTech position peaked at $31.1K in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.